Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-005045

Interim CEO & General Counsel gave up 36,441 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 83,325 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2023-01-17 Option exercise +83,325 85,325 D: show line 1 in the form
Vogt Frederick G Interim CEO & General Counsel 2023-01-17 Shares withheld for taxes −36,441 $6.43 $234,316 48,884 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2023-01-17 Option exercise · Restricted Stock Units −83,325 166,675 D: show line 3 in the form
Loading xslF345X03/tm233853d1_4seq1.xml…